Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2
Review
[키워드] anti-inflammatory compounds
Antibiotics
antiparasitic agent
Antiretrovirals
bortezomib
caused
Cell
cellular homeostasis
compounds
consequence
Convalescent patients
coronavirus
COVID-19
CoVs
Deleterious
Effect
effective
endoplasmic stress
global pandemic
Immunological response
in viral
inflammatory conditions
inhibitor
MG132
off-label
Oxygen administration
Patient
plasma
proteasome
proteasome inhibitors
protein expression
reduce
Replication
RNA
SARS-CoV-2
subsequent
supportive care
the cytokine storm
therapeutic
therapy
treated
Treatment
triggered
UPR response
virus entry
virus replication
[DOI] 10.3390/ijms21103622 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/ijms21103622 PMC 바로가기 [Article Type] Review